IP Verse

Novartis Pharmaceuticals competitive analysis

Latest publications and patents of Novartis Pharmaceuticals New

Explore the latest publications and patents granted to Novartis Pharmaceuticals, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Novartis Pharmaceuticals

Discover the latest PTAB cases involving Novartis Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Novartis Pharmaceuticals

IPR2023-01347Aug 28, 2023NOVARTIS PHARMACEUTICALSTHE REGENTS OF THE UNIVERSITY OF MICHIGANTerminated-Adverse Judgment
IPR2023-01346Aug 28, 2023NOVARTIS PHARMACEUTICALSTHE REGENTS OF THE UNIVERSITY OF MICHIGANFinal Written Decision - Appealed
IPR2022-00886Apr 20, 2022NOVARTIS PHARMACEUTICALSSHILPA PHARMAFinal Written Decision - Appealed
IPR2020-01263Aug 7, 2020BIOCON PHARMANOVARTIS PHARMACEUTICALSInstitution Denied
IPR2018-01287Jun 18, 2018NOVARTIS PHARMACEUTICALSPLEXXIKONInstitution Denied
IPR2018-00507Jan 17, 2018HIKMA PHARMACEUTICALSNOVARTIS PHARMACEUTICALSTerminated-Settled
IPR2017-01929Aug 16, 2017SUN PHARMACEUTICAL INDUSTRIESNOVARTIS PHARMACEUTICALSTerminated
IPR2017-01946Aug 15, 2017ACTAVIS ELIZABETHNOVARTIS PHARMACEUTICALSFinal Written Decision
IPR2017-01592Jun 12, 2017BRECKENRIDGE PHARMACEUTIALNOVARTIS PHARMACEUTICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Novartis Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NOVARTIS PHARMACEUTICALS - - 45Balanced
BIOCON PHARMA - - 1 - Highly Aggressive
BRECKENRIDGE PHARMACEUTIAL - - 1 - Highly Aggressive
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - 1 - 6Non-Active